src (dom. neg.) in pUSE amp, cDNA (K296R/Y528F) - Millipore
src (dom. neg.) in pUSE amp, cDNA (K296R/Y528F) - Millipore
src (dom. neg.) in pUSE amp, cDNA (K296R/Y528F) - Millipore
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>src</strong> (<strong>dom</strong>. <strong>neg</strong>.) <strong>in</strong> <strong>pUSE</strong> <strong>amp</strong>, <strong>cDNA</strong><br />
(<strong>K296R</strong>/<strong>Y528F</strong>)<br />
7.45 kb<br />
Catalog # 21-154<br />
Lot # 17759<br />
Product Description: Transfection grade eukaryotic<br />
expression vector conta<strong>in</strong><strong>in</strong>g mouse <strong>src</strong> (<strong>dom</strong>. <strong>neg</strong>.)<br />
under the control of the CMV promoter as illustrated.<br />
The <strong>cDNA</strong> was <strong>in</strong>serted as an H<strong>in</strong>d III fragment <strong>in</strong>to<br />
the H<strong>in</strong>d III site of <strong>pUSE</strong><strong>amp</strong>(+) multiple clon<strong>in</strong>g site<br />
(Catalog # 21-147).<br />
The <strong>dom</strong><strong>in</strong>ant <strong>neg</strong>ative <strong>src</strong> <strong>cDNA</strong> was derived from<br />
the neuronal form of c-<strong>src</strong> subjected to site directed<br />
mutagenesis to delete neuronal specific sequences.<br />
The <strong>cDNA</strong> conta<strong>in</strong>s two po<strong>in</strong>t mutations, the<br />
substitution of arg<strong>in</strong><strong>in</strong>e for lys<strong>in</strong>e at residue 296 and<br />
phenylalan<strong>in</strong>e for tyros<strong>in</strong>e at residue 528. NOTE:<br />
These residues correspond to K295 and Y527 <strong>in</strong> avian<br />
<strong>src</strong>.<br />
Formulation: 50mg aff<strong>in</strong>ity purified DNA eluted and<br />
packaged aseptically <strong>in</strong> 100ml 10mM Tris-HCl, pH 7.4,<br />
1mM EDTA. Frozen solution.<br />
Storage and Stability: Stable for 6 months at -20ºC<br />
from date of shipment.<br />
FOR RESEARCH USE ONLY<br />
NOT FOR USE IN HUMANS<br />
Quality Control Test<strong>in</strong>g<br />
Diagnostic DNA digest: This lot of DNA was cut with<br />
H<strong>in</strong>d III, which generated the expected fragments of<br />
approximately 1.9 and 5.5Kb.<br />
Purity: The OD260/OD280 for this lot of <strong>cDNA</strong> is 1.72.<br />
Expression <strong>in</strong> Transient Transfection Assay:<br />
Expression of <strong>src</strong> was detected by immunoblott<strong>in</strong>g of<br />
<strong>src</strong> (<strong>dom</strong>. <strong>neg</strong>.) <strong>in</strong> <strong>pUSE</strong><strong>amp</strong> transfected Cos-1 cells<br />
with 1μg/ml of anti-<strong>src</strong> (Catalog # 05-184).<br />
Immunoblot Analysis:<br />
RIPA lysates of transiently transfected Cos-<br />
1 cells were resolved by electrophoresis,<br />
transferred to nitrocellulose and probed with<br />
anti-<strong>src</strong> (Catalog #05-184, 1μg/ml).<br />
Prote<strong>in</strong>s were visualized us<strong>in</strong>g a goat antimouse<br />
secondary antibody conjugated to<br />
HRP and a chemilum<strong>in</strong>escence detection<br />
system. Lane 1, <strong>pUSE</strong> <strong>src</strong> (<strong>dom</strong>. <strong>neg</strong>.)<br />
transfected cells; Lane 2 untransfected<br />
control. Arrow <strong>in</strong>dicates <strong>src</strong>.<br />
Background: Src is the prototypical non-receptor prote<strong>in</strong> tyros<strong>in</strong>e k<strong>in</strong>ase whose activity is <strong>neg</strong>atively regulated by<br />
phosphorylation of a C-term<strong>in</strong>al tyros<strong>in</strong>e residue by the tyros<strong>in</strong>e k<strong>in</strong>ase Csk (C-term<strong>in</strong>al Src k<strong>in</strong>ase). Src is <strong>in</strong>volved <strong>in</strong><br />
multiple signal<strong>in</strong>g pathways, which <strong>in</strong>clude <strong>in</strong>tegr<strong>in</strong> mediated cell adhesion and growth factor <strong>in</strong>itiated cell proliferation.<br />
The substitution of arg<strong>in</strong><strong>in</strong>e for lys<strong>in</strong>e (residue 296) <strong>in</strong> the ATP b<strong>in</strong>d<strong>in</strong>g pocket of the tyros<strong>in</strong>e k<strong>in</strong>ase <strong>dom</strong>a<strong>in</strong> abolishes<br />
phosphotransferase activity. The phenylalan<strong>in</strong>e substitution for tyros<strong>in</strong>e (residue 528) abolishes phosphorylation and<br />
thereby prevents <strong>in</strong>tramolecular <strong>in</strong>teraction between the C-term<strong>in</strong>us and SH2 <strong>dom</strong>a<strong>in</strong> of Src. This k<strong>in</strong>ase <strong>in</strong>active <strong>src</strong><br />
mutant functions as a <strong>dom</strong><strong>in</strong>ant <strong>neg</strong>ative and renders the SH2 <strong>dom</strong>a<strong>in</strong>, and probably the SH3 <strong>dom</strong>a<strong>in</strong>, accessible to<br />
cellular b<strong>in</strong>d<strong>in</strong>g prote<strong>in</strong>s that normally contribute to activation of Src.
Page Two of Three<br />
Catalog # 21-154<br />
Lot 17759<br />
Application Reference:<br />
Mukhopadhyay, D., et al., Nature 375: 577-581, 1995.<br />
References:<br />
Zang, Q., et al., J. Biol. Chem. 272: 13275-13280, 1997.<br />
Brown, M.T., et al., Biochim. Biophys. Acta 1287: 121-149, 1996.<br />
Barone, M.V., et al., Nature 378: 509-512, 1996.<br />
Plasmid Information:<br />
Multiple Clon<strong>in</strong>g Site of <strong>pUSE</strong> (+) [5’?3’]:<br />
Nhe I<br />
Pme I<br />
Afl II<br />
H<strong>in</strong>d III<br />
Asp718 I<br />
Kpn I<br />
BamH I<br />
BstX I<br />
EcoR I<br />
EcoR V<br />
BstX I<br />
Not I<br />
Xho I<br />
Xba I<br />
Apa I<br />
Locations of <strong>cDNA</strong> Features:<br />
<strong>cDNA</strong> <strong>in</strong>sert: nt 912-2935<br />
<strong>src</strong> ORF: nt 1079-2686<br />
<strong>K296R</strong>: AAA to AGG nt 1967-1969<br />
<strong>Y528F</strong>: TAC to TCC nt 2663-2665<br />
PmeI<br />
Schematic Map of <strong>src</strong> (<strong>dom</strong>. <strong>neg</strong>.) <strong>cDNA</strong> :<br />
DNA Sequence:<br />
The complete sequence file of this plasmid is available<br />
at: www.upstatebiotech.com<br />
Transient transfection protocol for Cos-1 cells<br />
Note: The protocol described below has been optimized for Cos-1 cells. Successful transfection of each cell type<br />
requires optimization of the basic protocol. Variables to consider for optimization <strong>in</strong>clude, but are not limited to: cell<br />
density, transfection reagent, duration of transfection and DNA concentration.<br />
1. Seed a six-well tissue culture plate with 1-2 x 10 5 Cos-1 cells <strong>in</strong> 2ml of DMEM supplemented with 10% fetal calf<br />
serum. Incubate for 18-24 hours at 37ºC or until the cells are 40-60% confluent <strong>in</strong> a CO2 humidified <strong>in</strong>cubator.<br />
2. Dilute 1-2μg of DNA <strong>in</strong>to 100μl serum free DMEM <strong>in</strong> a sterile tube. To this tube, add 6μl of PLUS Reagent<br />
found <strong>in</strong> the LIPOFECTAMINE PLUS Reagent kit (Life Technologies). Allow mixture to stand for 15 m<strong>in</strong>utes<br />
at room temperature. In a second tube dilute 4μl of LIPOFECTAMINE Reagent <strong>in</strong>to 100μl serum free DMEM.<br />
3. Comb<strong>in</strong>e the two solutions, mix<strong>in</strong>g gently and <strong>in</strong>cubate at room temperature for 10-15 m<strong>in</strong>utes.<br />
4. Wash cells once with 2ml serum free DMEM.<br />
5. For each transfection, add 0.8ml serum-free medium to each tube conta<strong>in</strong><strong>in</strong>g the LIPOFECTAMINE PLUS<br />
Reagent - DNA complexes. Mix gently and overlay the complexes onto cells.<br />
6. Incubate the cells for 3 hours at 37ºC <strong>in</strong> a CO2 humidified <strong>in</strong>cubator.<br />
7. Remove the DNA-conta<strong>in</strong><strong>in</strong>g medium and replace with 2ml of DMEM supplemented with 10% fetal calf serum.<br />
Incubate cells 37ºC <strong>in</strong> a CO2 humidified <strong>in</strong>cubator for an additional 48-72 hours.<br />
H<strong>in</strong>d III<br />
8. Assay cell extracts for gene expression or activity at 48-72 hours post transfection.<br />
LIPOFECTAMINE PLUS IS a registered trademark of Life Technologies, Inc.<br />
Xba I<br />
<strong>src</strong> ORF<br />
H<strong>in</strong>d iii
Page Three of Three<br />
Catalog # 21-154<br />
Lot # 17759<br />
Restriction Endonuclease Map by Position: <strong>src</strong> (<strong>dom</strong>. <strong>neg</strong>.) <strong>in</strong> <strong>pUSE</strong><strong>amp</strong><br />
(Frequency < 3; Recognition sites >5 bp)<br />
Restriction sites found <strong>in</strong> <strong>in</strong>sert are <strong>in</strong> bold type.<br />
12 Bgl II<br />
12 NcrI<br />
55 StySJ<br />
161 MfeI<br />
161 Mun I<br />
180 Bpu10 I<br />
208 Nru I<br />
228 Afl III<br />
228 Mlu I<br />
249 Spe I<br />
484 Nde I<br />
590 BsaA I<br />
590 Eco105 I<br />
590 SnaB I<br />
593 Eco105 I<br />
876 Bsa I<br />
876 Eco31I<br />
895 Nhe I<br />
899 Ace II<br />
904 Pme I<br />
908 Afl II<br />
908 Bfr I<br />
908 Bst98 I<br />
911 Bbr I<br />
911 EcoVIII<br />
911 H<strong>in</strong>d III<br />
913 Bfr I<br />
918 BspDI<br />
918 Cla I<br />
961 EcoB I<br />
1031 Xba I<br />
1053 Xcm I<br />
1085 Bsg I<br />
1217 Mlu113 I<br />
1219 Sac II<br />
1220 Bsp120 I<br />
1224 Apa I<br />
1224 PpeI<br />
1246 Mlu113 I<br />
1248 Eco52 I<br />
1248 Sac II<br />
1248 Xma III<br />
1289 Tth111 I<br />
1328 UbaEI<br />
1330 BstE II<br />
1330 EcaI<br />
1342 BstX I<br />
1360 EclHK I<br />
1469 Age I<br />
1469 P<strong>in</strong>AI<br />
1489 Xcm I<br />
1518 Bpu10 I<br />
1593 PpuM I<br />
1610 Bsa I<br />
1610 Eco31I<br />
1721 Bsa XI<br />
1837 RleA I<br />
1846 Van91 I<br />
1935 PpuM I<br />
2000 Stu I<br />
2009 EcoN I<br />
2010 Sse8387 I<br />
2022 BspH I<br />
2041 StySJ<br />
2051 Ecoprr I<br />
2072 Bsg I<br />
2153 Ssp I<br />
2173 Van91 I<br />
2178 Afl III<br />
2178 BspLU11 I<br />
2201 CfrA I<br />
2239 PpuM I<br />
2274 SexA I<br />
2325 Bbs I<br />
2364 Van91 I<br />
2484 EcoRD3<br />
2498 EcoRD3<br />
2502 SexA I<br />
2622 Sse8387 I<br />
2624 Stu I<br />
2640 Bbs I<br />
2697 Fsp I<br />
2724 Bcg I'<br />
2739 UbaEI<br />
2758 Bcg I<br />
2809 Xmn I<br />
2872 Xcm I<br />
2890 EcoR I<br />
2890 HalI<br />
2890 SsoI<br />
2908 AccEBI<br />
2908 BamH I<br />
2908 BnaI<br />
2914 Xba I<br />
2934 Bbr I<br />
2934 EcoVIII<br />
2934 H<strong>in</strong>d III<br />
2940 Acc65 I<br />
2940 Asp718 I<br />
2944 Kpn I<br />
2945 Asp718 I<br />
2952 AccEBI<br />
2952 BamH I<br />
2952 BnaI<br />
2958 Spe I<br />
2971 BstX I<br />
2975 EcoR I<br />
2975 HalI<br />
2975 SsoI<br />
2984 M.SmaDam<br />
2987 EcoR V<br />
2997 BstX I<br />
3002 CciNI<br />
3002 Eco52 I<br />
3002 Not I<br />
3002 Xma III<br />
3007 BsuMI<br />
3007 Sex I<br />
3008 Ccr I<br />
3010 Sci I<br />
3013 Ccr I<br />
3014 Xba I<br />
3020 Bsp120 I<br />
3024 Apa I<br />
3024 PpeI<br />
3029 Pme I<br />
3037 BmeTI<br />
3038 Bcl I<br />
3060 EcoR124 I<br />
3240 Bbs I<br />
3374 Rsr II<br />
3446 NgoM I<br />
3448 Nae I<br />
3448 SauLPI<br />
3548 AdeI<br />
3551 BsaA I<br />
3554 Dra III<br />
3557 AdeI<br />
3608 Bsa XI<br />
3610 UbaD I<br />
3749 Xmn I<br />
3823 BstAPI<br />
3824 ApaB I<br />
3824 Ppu10 I<br />
3826 BfrB I<br />
3828 Nsi I<br />
3845 SexA I<br />
3895 BstAPI<br />
3896 ApaB I<br />
3896 Ppu10 I<br />
3898 BfrB I<br />
3900 Nsi I<br />
4077 Stu I<br />
4078 Avr II<br />
4128 BmeTI<br />
4129 Bcl I<br />
4147 BsaB I<br />
4147 Mam I<br />
4152 Mam I<br />
4194 Eco52 I<br />
4194 Xma III<br />
4390 Fsp I<br />
4406 Tth111 I<br />
4569 EcoR124 II<br />
4592 BsaA I<br />
4684 BscE I<br />
4684 BseP I<br />
4685 BssH II<br />
4690 BscE I<br />
4788 NgoM I<br />
4790 Nae I<br />
4790 SauLPI<br />
4804 Cpo I<br />
4804 Csp I<br />
4809 Cpo I<br />
4970 Cbi I<br />
4970 Csp45 I<br />
4970 Sfu I<br />
4974 Cbi I<br />
4974 Sfu I<br />
5071 NgoM I<br />
5073 Nae I<br />
5073 SauLPI<br />
5101 EcoD XXI<br />
5207 CfrA I<br />
5208 BsaM I<br />
5208 Bsm I<br />
5260 Bst1107 I<br />
5502 Bsa XI<br />
5519 StyLT III<br />
5639 Afl III<br />
5639 BspLU11 I<br />
5958 EcoRD2<br />
5971 EcoRD2<br />
6359 BspH I<br />
6532 EclHK I<br />
6593 Bsa I<br />
6593 Eco31I<br />
6754 Fsp I<br />
6758 Psp1406 I<br />
6902 Pvu I<br />
6902 Xor II<br />
6904 Xor II<br />
7012 Sca I<br />
7030 StyLT III<br />
7037 Bcg I'<br />
7071 Bcg I<br />
7131 Psp1406 I<br />
7131 Xmn I<br />
7189 EcoK I<br />
7189 StySP I<br />
7336 Ssp I<br />
7367 BspH I